Hjem › Galdevejscancer › Florida
Galdevejscancer kliniske forsøg i Florida
14 studier for Galdevejscancer søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06760819A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- Moffitt Cancer Center Magnolia Campus (Site 123), Tampa
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07265674A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Research Site, Gainesville
- Research Site, Jacksonville
- Research Site, Miami
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07221253A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- University of Florida College of Medicine ( Site 0281), Gainesville
- Mount Sinai Cancer Center ( Site 0287), Miami Beach
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06428409Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- AdventHealth Hematology and Oncology, Orlando
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT06282575Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Miami, Miami
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06293898AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Orlando
- Avenzo Therapeutics Recruiting Site, Sarasota
- Avenzo Therapeutics Recruiting Site, Tampa
RekruttererFase 1/2
Alder 18 til 75 · Alle køn · Opdateret 4. sep. 2026 · NCT07038343Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Research Site, Fort Myers
- Research Site, Jacksonville
- Research Site, St. Petersburg
- og 2 flere
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 19. aug. 2026 · NCT06467357A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- AdventHealth Celebration, Celebration
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT05592626D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
- Mount Sinai Medical Center, Miami Beach
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT06622057A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- University of Miami Hospital and Clinics, Miami
RekruttererFase 2
Alder 8 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT05503797A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT07458347Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT06239194Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
- Sylvester Comprehensive Cancer Center (University of Miami Hospital and Clinics), Miami
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. apr. 2026 · NCT05733598Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.